Results 231 to 240 of about 178,943 (330)

Foam fractionation studies of recombinant human apolipoprotein A-I. [PDF]

Biochim Biophys Acta Biomembr
Lethcoe K, Fox CA, Hafiane A, Kiss RS, Liu J, Ren G, Ryan RO.   +6 more
europepmc   +1 more source

Apolipoprotein A-I possesses an anti-obesity effect associated with increase of energy expenditure and up-regulation of UCP1 in brown fat [PDF]

, 2010
Xiangbo Ruan, Zhenghu Li, Yixuan Zhang, Ling Yang, Yi Pan, Zhenzhen Wang, Gen‐Sheng Feng, Yan Chen   +7 more
openalex   +1 more source

Uncovering the Complexity of Synucleinopathies: An Ongoing Tale Between Proteins and Lipids

Movement Disorders, EarlyView.
Abstract Neurodegenerative diseases are pathological states characterized by progressive alterations in brain homeostasis during aging. Synucleinopathies, including Parkinson's disease and dementia with Lewy bodies, are defined neuropathologically by the accumulation of inclusions known as Lewy bodies and Lewy neurites.
Manuel Flores‐León, Tiago F. Outeiro
wiley   +1 more source

Molecular Simulation of the Binding of Amyloid Beta to Apolipoprotein A-I in High-Density Lipoproteins. [PDF]

Int J Mol Sci
Malajczuk CJ, Mancera RL.
europepmc   +1 more source

N-terminal eGFP-tagging of rabbit apolipoprotein A-I decreases expression and impairs cholesterol-efflux activity. [PDF]

Biochim Biophys Acta Mol Cell Biol Lipids, 2023
Wacker BK, Bi L, Liu L, Sorci-Thomas MG, Ng P, Palmer DJ, Tang C, Dichek DA.   +7 more
europepmc   +1 more source

Human Cyclophilins—An Emerging Class of Drug Targets

Medicinal Research Reviews, EarlyView.
ABSTRACT Cyclophilins are a family of enzymes with peptidyl‐prolyl isomerase activity found in all cells of all organisms. To date, 17 cyclophilin isoforms have been identified in the human body, participating in diverse biological processes. Consequently, cyclophilins have emerged as promising targets for drug development to address a wide array of ...
Katarina Jurkova, Hana Navratilova, Kamil Musilek, Ondrej Benek   +3 more
wiley   +1 more source

Overexpression of Apolipoprotein A-I Alleviates Insulin Resistance in MASLD Mice Through the PPARα Pathway. [PDF]

Int J Mol Sci
Wang Y, Zhang Y, Wang Y.
europepmc   +1 more source

Predictive and prognostic role of early apolipoprotein A-I alteration in recurrent or metastatic nasopharyngeal carcinoma patients treated with anti-PD-1 therapy. [PDF]

Cancer Med, 2023
Xiao BJ, Sima XX, Chen G, Gulizeba H, Zhou T, Huang Y.   +5 more
europepmc   +1 more source

Evolution of mammalian apolipoprotein A-I and conservation of antigenicity: correlation with primary and secondary structure

, 1997
Xavier Collet, Yves L. Marcel, Nathalie Tremblay, Claude Lazure, R W Milne, Bertrand Perret, P K Weech   +6 more
openalex   +1 more source

CEST MRI Processing Pipeline in Pilot Study of Alzheimer's Disease Patients

Magnetic Resonance in Medicine, EarlyView.
ABSTRACT Purpose To develop a processing pipeline combining neuroimaging analysis tools with CEST postprocessing and utilize it in a pilot study probing differences between cognitively impaired (CI) Alzheimer's disease (AD) patients and cognitively normal (CN) individuals.
Alexander Asturias, Fang Frank Yu, Elizabeth M. Davenport, Brendan J. Kelley, Ivan E. Dimitrov, Jochen Keupp, Elena Vinogradov   +6 more
wiley   +1 more source